$2.65
+0.01 (+0.38%)
Open$2.64
Previous Close$2.64
Day High$2.70
Day Low$2.64
52W High$4.66
52W Low$2.54
Volume—
Avg Volume105.3K
Market Cap1.33B
P/E Ratio—
EPS$-0.02
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,027.5% upside
Current
$2.65
$2.65
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 192.49M | 164.74M | 608.59M |
| Net Income | -12,385,958 | -9,540,707 | 77.66M |
| Profit Margin | -6.4% | -6.1% | 12.8% |
| EBITDA | -34,036,212 | -27,674,085 | 120.12M |
| Free Cash Flow | — | — | 67.66M |
| Rev Growth | +16.8% | +16.8% | +15.9% |
| Debt/Equity | — | — | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |